Ractigen Therapeutics, a clinical-stage biopharmaceutical company pioneering small activating RNA (saRNA) therapeutics, today announced the presentation of positive preliminary data from its ongoing ...

SINGAPORE – A new programme has launched in Singapore to formally study the applications of ribonucleic acid (RNA) in vaccine ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...